行情

FCSC

Fibrocel Science
FCSC
NASDAQ
已退市
市盈率(FWD)
市销率
市净率
市值
-2.0744
1.337
2.726
29,274,996.00
关于 FCSC
Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related. It is investigating the indication in a Phase II clinical trial. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. Its product, LAVIV (azficel-T), is indicated for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. A third gene-therapy program is focused on the treatment of arthritis. Its product, LAVIV (azficel-T), is focused on improving the appearance of nasolabial fold wrinkles in adults.
展开

FCSC 新闻

更多
优衣库母公司迅销第三财季亏损98.2亿日元
新浪财经 · 1小时前
沪指震荡上扬 科技股飙升助推纳指再创新高
新浪财经 · 1小时前
史上首次!惠誉:疫情下垃圾级主权债数量将超过投资级
环球外汇网 · 3小时前
联想推出“6+”行业智能化服务方案 智慧城市和教育受专家认可
新浪财经 · 3小时前
降息引来马来西亚股市交投热烈 成交量已超256.8万股
央视 · 3小时前
英伟达市值超越英特尔
新浪财经 · 6小时前
阿里巴巴暴涨7% 市值达5.4万亿港元再超腾讯
新浪科技 · 6小时前
美联航发出重大裁员警告:裁员3.6万人 占总数1/3
新浪财经 · 7小时前

热门股票

代码
价格
涨跌幅

微牛提供Fibrocel Science(NASDAQ-FCSC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的FCSC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易FCSC股票基本功能。